Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT00197496 Completed - Hip Fracture Clinical Trials

Body Weight Supported Treadmill Training Following Hip Fracture

Start date: January 2007
Phase: N/A
Study type: Interventional

Achieving independent ambulation is an important goal of hip fracture rehabilitation, as it is predictive of returning to the community and of future health problems. Current research regarding post-hip fracture rehabilitation is sparse. Body weight supported treadmill training (BWSTT) is a novel approach to retrain walking abilities. BWSTT may be ideal for retraining walking after hip fracture, as it is task-specific and alleviates the demands of maintaining balance while walking skills are trained. The use of the harness may provide a sense of security for the patient, facilitating walking training. The proposed project will investigate the feasibility and tolerability of BWSTT after hip fracture, and its impact on function, mobility, quality of life and fear of falling. It is hypothesized that BWSTT 3-5 times weekly in acute hip fracture patients will improve function, mobility, quality of life and reduce fear of falling.

NCT ID: NCT00189514 Completed - Obesity Clinical Trials

A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Start date: September 2005
Phase: Phase 2
Study type: Interventional

This is a long term extension to study 137OB-201 which is designed to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects.

NCT ID: NCT00177593 Completed - Obesity Clinical Trials

The Effect of HealthWear on Short-Term Weight Loss

Start date: June 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to examine the effect of a computer tracking system and energy expenditure device on weight loss in adults.

NCT ID: NCT00153790 Completed - Weight Loss Clinical Trials

LEAN Project: Weight Loss and Appetite Suppression

Start date: April 2005
Phase: Phase 1
Study type: Interventional

The primary aim is to examine whether the intake of PhosphoLEAN is effective in aiding a cohort of women in losing weight. Participants taking the supplement will have significantly greater improvement in study outcomes than those taking the placebo.

NCT ID: NCT00138645 Completed - Body Weight Changes Clinical Trials

The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet

FORMULA
Start date: April 2005
Phase: Phase 4
Study type: Interventional

It is hypothesized that the use of a partial supplement diet, which includes the use of meal replacements, will result in significantly greater weight loss after three and six months compared to an isocaloric diet that does not include supplements. It is also hypothesized that the partial supplement diet will result in larger improvements in body composition, disease biomarkers, and health parameters (blood pressure, lipids) compared to the non-supplement diet. Finally, it is hypothesized that subjective ratings of satiety will be significantly higher, and ratings of hunger lower, in the group consuming a partial supplement diet.

NCT ID: NCT00134290 Completed - Insulin Resistance Clinical Trials

The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance

Start date: January 2002
Phase: Phase 4
Study type: Interventional

This is a study to: - Determine the difference between strong hypo-energetic "standard diet advice" and modest hypo-energetic "personal diet advice"; and - Determine the influence of insulin-insensitivity on obesity and weight reduction by treating patients with metformin or placebo.

NCT ID: NCT00130286 Completed - HIV Infections Clinical Trials

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Start date: March 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to determine if the combination of recombinant human growth hormone plus rosiglitazone (an insulin-sensitizing drug) is safe and more effective than either drug alone (or no active therapy) for the treatment of fat accumulation in people with HIV infection and insulin resistance.

NCT ID: NCT00120562 Terminated - Obesity Clinical Trials

Studies of Biological Changes Related to Weight Loss After Gastric Bypass Surgery

Start date: July 2007
Phase: Phase 2
Study type: Observational

Weight loss achieved by dieting induces multiple changes. These changes include a decrease in metabolic rate (the rate in which the body burns its calories), an increase in appetite and other physiological and hormonal changes that may be the cause of failure in dieting. Many of these parameters that have never been evaluated when weight is lost after gastric bypass surgery will be tested in this study.

NCT ID: NCT00115271 Completed - Pregnancy Clinical Trials

Antenatal Micronutrient Supplementation and Birth Weight

Start date: January 1999
Phase: Phase 3
Study type: Interventional

The purpose of this study was to determine the effects of providing supplements containing alternative combinations of micronutrients during pregnancy on birth weight and other infant and maternal health and nutritional outcomes in a rural area of Nepal.

NCT ID: NCT00114543 Completed - Infant, Premature Clinical Trials

Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight

Phototherapy
Start date: September 2002
Phase: Phase 3
Study type: Interventional

This multi-center, randomized clinical trial compared different bilirubin levels as thresholds for timing of phototherapy in extremely low birth weight infants. The primary hypothesis was that there would be no difference in death or neurodevelopmental impairment at 18-22 months corrected age in infants treated by either aggressive or conservative threshold limits. 1,978 infants were enrolled.